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Background: Both chronic hypoxia (CH) and long-term chronic intermittent hypoxia
(CIH) exposure lead to right ventricular hypertrophy (RVH). Weight loss is an effective
intervention to improve cardiac function and energy metabolism in cardiac hypertrophy.
Likewise, caloric restriction (CR) also plays an important role in this cardioprotection
through AMPK activation. We aimed to determine the influence of body weight
(BW) on RVH, AMPK and related variables by comparing rats exposed to both
hypoxic conditions.
Methods: Sixty male adult rats were separated into two groups (n = 30 per group)
according to their previous diet: a caloric restriction (CR) group and an ad libitum (AL)
group. Rats in both groups were randomly assigned to 3 groups: a normoxic group (NX,
n = 10), a CIH group (2 days hypoxia/2 days normoxia; n = 10) and a CH group (n = 10).
The CR group was previously fed 10 g daily, and the other was fed ad libitum. Rats
were exposed to simulated hypobaric hypoxia in a hypobaric chamber set to 428 Torr
(the equivalent pressure to that at an altitude of 4,600 m above sea level) for 30 days.
Measurements included body weight; hematocrit; serum insulin; glycemia; the degree
of RVH (Fulton’s index and histology); and AMPK, mTOR, and PP2C expression levels
in the right ventricle determined by western blotting.
Results: A lower degree of RVH, higher AMPK activation, and no activation of mTOR
were found in the CR groups exposed to hypobaric hypoxia compared to the AL groups
(p < 0.05). Additionally, decreased glycemia and serum insulin levels were observed.
Interestingly, PP2C expression showed an increase in the AL groups but not in the CR
groups (p < 0.05).
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Conclusion: Maintaining a low weight before and during exposure to high-altitude
hypoxia, during either CH or CIH, could prevent a major degree of RVH. This
cardioprotection would likely be due to the activation of AMPK. Thus, body weight is
a factor that might contribute to RVH at high altitudes.
Keywords: right ventricle hypertrophy, hypobaric hypoxia, AMPK, body weight, high altitude
INTRODUCTION
Exposure to hypoxic environments under both chronic
hypoxia and long-term chronic intermittent hypoxia induces
cardiopulmonary changes that allow the maintenance of the
circulatory demands and the homeostasis of tissues under
conditions of limited oxygen availability (Ostadal et al., 1998).
Under Long-term chronic intermittent hypoxia condition
individuals work at a high altitude for days and rest at sea level
for the same period (Richalet et al., 2002). Hypoxia exposure
elevates pulmonary artery pressure by vasoconstriction (Von
Euler and Liljestrand, 1946; Moudgil et al., 2005), and after a
long period of exposure there is a remodeling of pulmonary
vasculature leading to right ventricular hypertrophy (RVH)
(Brito et al., 2007, 2018; Penaloza and Arias-Stella, 2007).
Cardiac hypertrophy is associated with increased
cardiomyocyte cell volume, enhanced protein synthesis, and
changes in gene transcription and translation (Glennon et al.,
1995). Additionally, human studies and animal experimental
models have identified that right ventricular dysfunction due
to pressure overload is associated with metabolic derangements
(Ryan and Archer, 2014). Because of its particular role, the heart
requires high metabolic activity due to constant overloading
(Noppe et al., 2014).
AMP-activated protein kinase (AMPK) is a heterotrimeric
protein kinase composed of a catalytic α subunit and two
regulatory subunits (β & 7). As an intracellular energy sensor,
in the heart, AMPK is activated in response to an increase in
the AMP/ATP ratio under stress conditions such as hypoxia,
hypertrophy and hypoglycemia (Arad et al., 2007; Viollet et al.,
2009). Studies in mice revealed that AMPK activation attenuates
the development of cardiac hypertrophy by inhibiting protein
synthesis and activating autophagy (Chan et al., 2004, 2008;
Kang et al., 2011; Li et al., 2014). AMPK activation can also
increase the uptake of glucose, enhance fatty acid oxidation
(Dyck and Lopaschuk, 2006; Nagendran et al., 2013) and inhibit
protein synthesis to reserve energy stores (Liu et al., 2006).
Therefore, AMPK would have a protective role by restoring
the energy balance and a key role against cardiovascular
diseases and cellular stress (Dolinsky and Dyck, 2006). This
role has been seen in humans under chronic hypoxia (CH)
(Zhang et al., 2018) but has rarely been studied in hypobaric
chronic intermittent hypoxia (CIH). The cardioprotective role
of the AMPK pathway against cardiac hypertrophy involves
mammalian target of rapamycin (mTOR), which is a major
regulator of myocardial protein synthesis and a major driver of
cardiac hypertrophy (Proud, 2004) whose activation regulates
cell proliferation, apoptosis, cell migration and metabolism
(Li et al., 2014). However, the inactivation of AMPK by
dephosphorylation has been described to be attributed to PP2C
(Davies et al., 1995; Marley et al., 1996; Steinberg, 2007). PP2C is
a protein serine/threonine phosphatase that controls the specific
dephosphorylation of thousands of phosphoprotein substrates
(Shi, 2009). The primary function of PP2C appears to be the
regulation of stress signaling, although it also plays a role in
cell differentiation, growth, survival, apoptosis, and metabolism
(Lu and Wang, 2008).
The impact of caloric restriction (CR) on inducing weight
loss in cardiac hypertrophy has substantial clinical importance
(Karwi et al., 2019). Recently, it has been reported in both humans
and animal models that overweight and obesity influence high-
altitude illness outcomes such as pulmonary hypertension (San
Martin et al., 2017; Brito et al., 2018). Studies in mice show that
CR is a potent dietary intervention to produce beneficial cardiac
effects (Kobara et al., 2015; Melo et al., 2016) through AMPK
activation, which plays an important role in cardioprotection
(Shinmura et al., 2005, 2008; Chen et al., 2013).
The impact of a change in body weight before and during
exposure to hypoxia at a high altitude, as well as the activation of
AMPK in RVH, is not well known. Therefore, it is hypothesized
that during high-altitude hypobaric hypoxia, a lower body weight
would promote a reduced RVH through the activation of AMPK.
Thus, the aim of this study was to determine the influence of body
weight (BW) on RVH, through caloric restriction compared to
an ad libitum food intake regimen, as well as its association with
AMPK and related variables, by comparing rats exposed to both
hypoxic conditions (CIH and CH).
MATERIALS AND METHODS
Animal Model
The model used for this experiment was largely described and
validated previously in several studies (Siques et al., 2006).
The study was performed on sixty male Wistar rats (12 weeks
of age) obtained from the animal facility of the Institute of
Health Studies of Arturo Prat University, Iquique, Chile. The
rats were assigned to two groups according to the amount of
food provided during the previous month of exposure (CR
10 g and AL daily). Then, it was obtained a CR group (body
weight 251.6 ± 1.9 g; n = 30), which received 10 g/day of food
(Corresponding to caloric restriction 70%), and an ad libitum
(AL) group (body weight 434.6 ± 5.9 g; n = 30). This model
of caloric restriction is based on the works in rats of Kobara
et al. (2015) and Melo et al. (2016). Then, both groups were
randomly divided into three groups: (1) a normobaric normoxia
(NX) group (n = 10), which served as a sea-level control; (2) a
chronic intermittent hypobaric hypoxia (CIH) group (n = 10),
Frontiers in Physiology | www.frontiersin.org 2 April 2020 | Volume 11 | Article 342
fphys-11-00342 April 20, 2020 Time: 15:21 # 3
Flores et al. AMPK in Long-Term Hypobaric Hypoxia
which underwent 2 days of exposure to hypobaric hypoxia
alternating with 2 days of exposure to normobaric normoxia;
and (3) a chronic hypobaric hypoxia (CH) group (n = 10),
which underwent permanent exposure to hypobaric hypoxia.
All groups received water ad libitum and a standard balanced
diet for laboratory rats (22.0% crude protein, 5.0% crude fat,
5.0% crude fiber, 9.0% ash and 12% moisture (5POO R©, LabDiet R©,
Prolab RMH3000). Food intake was measured through the
determination of the amount of residual food, and fasting times
were accurately controlled. The exposure time of each group was
30 days, and hypobaric hypoxia was simulated in a chamber
at 428 Torr (equivalent to an altitude of 4,600 m above sea
level). The time of ascension from sea level to 4,600 m above sea
level was 60 min.
The chamber conditions were as follows: internal flow of
3.14 L/min of air and humidity between 21 and 30%. NX groups
were located in the same room at sea level (760 Torr) and housed
under the same chamber conditions as the groups exposed to
hypoxia. The rats were placed in individual cages at a temperature
of 22 ± 2◦C and a circadian rhythm of 12 h of light and 12 h
of dark. Movement inside the cage was not restricted, but no
exercise was performed. At the end of the exposure period, the
rats were euthanized with an overdose of ketamine (0.9 mg/kg of
weight), organs were collected and stored at −80◦C, and specific
variables were measured.
The animal protocol and experimental model were in
accordance with Chilean Law No. 20380 regarding animal
experimentation and were approved by the Research Ethics
Committee of Arturo Prat University, Iquique, Chile.
Body Weight, Hematocrit, Blood
Glucose, and Serum Insulin
Both biochemical and physiological parameters in all study
groups were measured at day 0 under basal normoxic conditions
and after 30 days immediately after removal from the chamber.
The body weight and residual food were measured using an
electronic scale (Acculab V-1200 R©, Chicago, IL, United States).
Blood extraction (1 mL) for biochemical measurements was
performed via cardiac puncture under anesthesia (0.3 mg/kg
body weight) after 10 h of fasting. The hematocrit (Hct) values,
calculated as percentages, were measured using capillaries, which
were centrifuged (5804 R Eppendorf AG R©, Hamburg, Germany)
at 5,000 rpm for 5 min. Glucose in blood was measured using
a glucometer (CarenSensN R©), and serum insulin was measured
using a commercial kit (Reta Insulin ELISA Kit R©, ALPCO, Salem,
VT, United States).
Western Blot Analysis
For protein analysis, 50 mg of right ventricular cardiac
muscle was obtained from each rat. Protein extraction was
started by tissue homogenization (Stir-Pak R©, Barrington, IL,
United States) with 500 µL RIPA lysis buffer, which contains a
mixture of phosphatase and protease inhibitors (4 mM PMSF,
10 µM leupeptin, 1 mM EDTA, 1 mM EGTA, 20 mM NaF,
20 mM HEPES and 1 mM DTT). Then, the homogenates
were centrifuged (5804 R Eppendorf AG R©, Hamburg, Germany)
at 12,000 rpm for 20 min at 4◦C, and the supernatant
was extracted. For the quantification of the total protein
extracted, the Bradford reaction was used (Bradford, 1976)
with a BioPhotometer (Eppendorf AG R©, Hamburg, Germany)
at 590 nm, and samples were then stored at −80◦C. For
western blotting, the samples were previously diluted with 2X
Laemmli buffer [0.125 M Tris-HCl, 4% SDS (p/v), 20% glycerol
(v/v), 0.004% bromophenol blue, 10% β-mercaptoethanol (pH
6.8)]. Then, 50 µg of the protein were separated according
to their molecular weight (MW) under an electric field via
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) (30% bis-acrylamide (v/v), 150 mM Tris (pH 6.8 and
8.8), 1.0% TEMED (w/v), H2O) at 6 and 12%. Electrophoretic
separation was initiated with the application of direct current
to 150 V over 80 min with a power supply (PolyScience R©,
EPS-300, Taipei, Taiwan, China), and the proteins were then
transferred from the polyacrylamide gel to a polyvinylidene
difluoride (PVDF) membrane at 180 mA for 90 min with a
semidry electroblotting system (OwlTM HEP systems, Thermo
Fisher Scientific R©, United States).
To avoid nonspecific antibody binding, the PVDF membrane
was blocked with bovine serum albumin (BSA) at a concentration
range of 3–5% in TBS-T solution containing 10 mM HCl,
150 mM NaCl, and 0.05% Tween-20 at pH 7.4. The blocking
time was 1 h at room temperature. Then, the membrane
was incubated with the corresponding primary antibodies
[AMPKα1/2 (sc-25792), p-AMPKα1/2 (sc-101630), mTOR (sc-
517464), p-mTORC1 (sc-293133), PP2Cα (sc-517264), and
β-actin (sc-130657)] at a dilution of 1:500 (Santa Cruz
Biotechnology R©, Santa Cruz, CA, United States) and incubated
overnight at 4◦C. Finally, the membrane was incubated
with secondary antibodies (anti-goat, anti-rabbit and anti-
mouse antibodies, Santa Cruz Biotechnology R©, Santa Cruz, CA,
United States) at a dilution of 1:2,000 in 3% BSA for 1 h at room
temperature, washed with TBS-T and then imaged in a dark room
with a chemiluminescence kit (Chemiluminescence West Pico R©,
Super Signal Substrate, Thermo Fisher Scientific R©, Rockford,
IL, United States). The density of the bands was measured
with ImageJ software and normalized according to β-actin
expression and Ponceau staining. The activity levels of AMPK
and mTOR were determined by the ratio of phosphorylated
protein to total protein.
Right Ventricular Hypertrophy and
Histology
RVH was evaluated at the end of the exposure period
(day 30) using Fulton’s index [RV/LV+Septum (g/g)], as
described previously (Kay, 1980). Also, total ventricles weight
vs. body weight ratio was obtained (g/g). For morphological
assessment under light microscopy, the ventricular tissue was
cut transversally and fixed in 4% paraformaldehyde at room
temperature overnight and then dehydrated and embedded in
paraffin. Paraffin-embedded tissue slices (5 µm thick) were
routinely stained with hematoxylin and eosin (H&E) and finally,
the area was measured through ImageJ software.
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Data Analysis
All data recorded were included in a database and analyzed
using the SPSS program (IBM SPSS R© V.21.0 R©, Armonk, NY,
United States). The normality of the variables was established
by the Kolmogorov-Smirnov test, and all variables had a
normal distribution. The means and standard errors (SEs) were
calculated for all variables. To determine differences in the
measured variables over time, a paired-sample Student’s t test was
performed between the two groups. To establish the intergroup
differences, repeated-measures analysis of variance (ANOVA)
was used. For variables measured once, an independent Student’s
t test and one-way ANOVA followed by the least significant
difference (LSD) post hoc test were performed. The level of
significance was established at the 95% confidence level, with
p < 0.05 considered indicative of significance.
RESULTS
Body Weight, Hematocrit, Blood
Glucose, and Serum Insulin
Previous exposure body weight was decreased in CR compared
to AL group (p < 0.001) (Figure 1A). The body weight was lower
in both the AL and the CR hypoxia-exposed groups (CIH and
CH) than in the NX group (p < 0.001) at the end of exposure
day 30 (Figure 1B). Remarkably, the AL group lowered their
weight by a greater proportion than the CR group (p < 0.001).
Importantly, food intake under CH in both the AL and CR groups
was similar (10 g), whereas under CIH, both groups showed
reduced intake, with less intake in the AL group than in the CR
group while they were in the chamber. Interestingly, CR group
under chronic hypoxia did not further reduce the food intake.
Despite this observation, the AL group showed a higher weight
than the CR group at the end of the exposure.
Both the AL- and CR-exposed groups exhibited a decrease
in blood glucose levels and serum insulin compared to the NX
groups and basal levels (p < 0.01). Interestingly, the CR group
exposed to CIH showed lower insulin levels than the AL group
exposed to CIH (p < 0.01) (Figures 1C,D).
Under hypobaric hypoxic conditions (CIH and CH), both
the AL and CR groups showed an increase in Hct compared to
the NX groups and basal levels (p < 0.001), with values being
higher in the CH groups (p < 0.01). Notably, this increase was
less in the CR groups than in the AL groups exposed to CH
(p < 0.01) (Figure 1E).
Right Ventricular Hypertrophy
RVH was observed in both the AL and CR groups under
hypobaric hypoxic conditions compared to the NX groups
(p < 0.01) and was higher in the CH groups than in the CIH
groups. Remarkably, a lower degree of hypertrophy was observed
in the CR group than in the AL group (p < 0.05), and the
degree of hypertrophy observed in the CR group under CH was
similar to that in the AL group under CIH (Figure 2A). Similar
results were found with total ventricles weight vs. body weight
ratio (Figure 2B). Representative images and the quantification
of the area clearly show the enlargement of myocytes, which was
coincident with the hypertrophy found in the CR and AL groups
(Figures 2C,D). Interestingly, the weights of both ventricles (RV
and LV) in rats of the AL group were higher than those in the CR
group, as expected.
AMPK, mTOR, and PP2C Expression
Levels
AMPK activation was increased only in the CR groups under both
CIH and CH (p < 0.05), while the AL groups showed no AMPK
activation. Interestingly, in this latter group, a decrease in AMPK
under CH was found (p < 0.05) (Figures 3A,D).
Conversely, in the CR groups under both CIH and CH,
there was no mTOR activation and no overexpression of
PP2Cα, while in the AL group, there was a higher activation
and expression of both proteins under CH than under CIH
(p < 0.05) (Figures 3B–D).
DISCUSSION
This research on long-term CIH and CH right ventricular
hypertrophy revealed important and novel findings. Caloric
restriction results in: (1) reduced RVH; (2) activation of AMPK;
and (3) no activation of mTOR and PP2Cα was seen.
This research is in line with other studies and calls attention
to the importance of a low body weight to decrease cardiac risk
(Riordan et al., 2008; Derumeaux et al., 2017) with ventricular
hypertrophy (Karwi et al., 2019). However, the influence of body
weight on AMPK activation in RVH induced by CH and long-
term CIH exposure has received little attention.
In this study, both the AL and CR groups lost body weight
and had lower blood glucose and serum insulin levels due to the
metabolic effects of hypoxia, as has been reported with hypobaric
and hypoxic hypoxia models (Chiu et al., 2004; Gamboa et al.,
2011; Siques et al., 2018). Moreover, the CR group not only lost
body weight under hypoxia but also began exposure with a lower
body weight than did the AL group. These results call attention
to the importance of maintaining a low body weight before and
during exposure to long-term hypobaric hypoxia.
Interestingly, regarding hematocrit, the CR group had a lower
hematocrit before the exposure, with no difference among the
groups. This result is consistent with those of some authors, who
explain that this lower hematocrit is the effect of decreased intake
of dietary energy and of blood-forming nutrients (Faris et al.,
2012; Gasmi et al., 2018). Despite the possible influence of CR
in the hematocrit level, it is important to highlight that the all
exposed to hypoxia groups had elevated hematocrit at day 30.
On the other hand, the model of this study is effectively an
unusual model of exposure that is scarcely known. Food intake
clearly has an effect on insulin level, but the regimen and degree
of hypoxia are also extremely important, which is in agreement
with the results of Debevec and Millet (1985), who demonstrated
that the regimen and the degree of hypoxia can lead to variation
in the results. In our results, the degree of hypoxia was the most
important variable because it determined the amount of food
intake, although the difference was not significant between the
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FIGURE 1 | Physiological and biochemical parameters: Ad libitum (AL) and caloric restriction (CR) groups on days 0 and 30: normoxic group (NX), chronic
intermittent hypoxia group (CIH), and chronic hypoxia group (CH). (A) Body weight (g) previous to exposure, (B) Body weight (g) during exposure, (C) Blood glucose
(mg/dl) and (D) Serum insulin (ng/ml) (E) Hematocrit (%). The values are the mean (x̄) ± standard error (SE). ∗p < 0.05: hypoxia-exposed vs. NX; #p < 0.05: CIH vs.
CH. †p < 0.05: AL vs. CR; ‡Day 30 vs. Day 0 for each group NX, CIH and CH of AL and CR groups.
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FIGURE 2 | Grade of right ventricular hypertrophy (RVH): Ad libitum (AL) and caloric restriction (CR) groups on day 30: normoxic group (NX), chronic intermittent
hypoxia group (CIH), and chronic hypoxia group (CH). (A) Expressed as Fulton’s index [right ventricle (RV) weight/(left ventricle (LV) weight + septum weight)].
(B) Ventricles (RV+S+LV)/BW ratio. (C) Hematoxylin and eosin staining of the slices of the RV and (D) of the cardiomyocyte area of the RV. The values are the mean
(x̄) ± standard error (SE). ∗p < 0.05: hypoxia-exposed vs. NX; #p < 0.05: CIH vs. CH. †p < 0.05: AL vs. CR.
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FIGURE 3 | Protein expression levels in the right ventricle (RV): Ad libitum (AL) and caloric restriction (CR) groups at day 30: normoxic group (NX), chronic intermittent
hypoxia group (CIH), and chronic hypoxia group (CH). (A) Activation of AMPK (p-AMPK/total AMPK ratio); (B) Activation of mTOR (p-mTOR/total mTOR ratio)
normalized by β-actin; (C) PP2Cα expression levels, normalized by Ponceau staining; and (D) Representative bands are shown. Values are means (X) ± standard
errors (SEs). ∗p < 0.05: hypoxia-exposed vs. NX; #p < 0.05: CIH vs. CH. †p < 0.05: AL vs. CR.
CR and the AL in CH groups. Interestingly, AL groups, in both
hypoxia conditions show a decrease of food-intake and a possible
explanation could be attributed to the hypoxic stressor and its
side effects (San Martin et al., 2017).
Conversely, the CIH groups eat differently under hypoxic
stimuli. Those fed ad libitum eat 4.5 g; however, the CR group
eat an average of 7.9 g. The AL groups could have been affected
by anorexia and general malaise, as occurs in humans (acute
mountain sickness), and particularly so when just slightly over
a healthy body weight (as described by San Martin et al., 2017).
Furthermore, the AL group maintained a substantial amount
of fat tissue, which has an influence in insulin. Additionally,
insulin sensitivity has been demonstrated to be increased in
hypoxia (Chiu et al., 2004; Gamboa et al., 2011). Therefore, both
food intake and hypoxia regimen would contribute to determine
insulin levels, highlighting that the kind and degree of hypoxia
might be the most critical.
Ventricular hypertrophy) is characterized by increased
cardiomyocyte size, a higher degree of sarcomere organization
and enhanced protein synthesis levels, all of which are closely
associated with energy metabolism (Tham et al., 2015). Human
studies in the same model of CIH showed that this hypertrophy
is associated with cardiometabolic factors, among others (Brito
et al., 2018). Our results demonstrate RVH in those exposed
to hypoxia, and importantly, that RVH in CR is lesser than
in AL. Although, in this study does not seems to be restricted
to the latter, because CR rats eat more food than AL inside
the chamber in CIH condition; and the CR rats did developed
RVH as well but at a lesser, only under hypoxic conditions,
where AMPK pathway might play a major role as is discussed
below. However, in the current study, it is clear that with CR,
the hypoxia regimen increased the AMPK activity and inhibited
mTOR, which might explain the degree of RVH that was found.
The weights of both ventricles, including LV, in rats of the AL
group were higher than those in the CR group, as expected
because of the pre-exposure weight.
AMPK is known as an energy sensor and a regulator of
cardiac energy metabolism under normal and stress conditions.
Additionally, AMPK has been shown to inhibit cardiac
hypertrophy (Sung et al., 2015) and to have a role beyond
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metabolic regulation. It also plays a critical role in an
ample variety of cellular processes, such as regulating protein
synthesis, transcriptional activity and energy supply (Baskin
and Taegtmeyer, 2011; Cates et al., 2018; Feng et al., 2018).
Additionally, CR-induced relative energy deficits, such as
hypoxia, hypertrophy and hypoglycemia, result in increased
intracellular levels of the AMP/ATP ratio, activating AMPK
(Arad et al., 2007; Viollet et al., 2009). Our study (caused by
pressure overload as a consequence of hypoxia) presents all of
the above stressors; however, only CR groups that began with a
lower body weight prior to exposure and maintained it exhibited
the activation of AMPK activation and lower RVH. Similarly,
other studies demonstrate other pathways that involve AMPK,
showing nutrient deprivation produce an increase of AMPK
activity, and this activation decreases the cardiac remodeling
through degradation of hypertrophic proteins mediated by
AMPK-induced transcription factors, such as MEF2 (Baskin and
Taegtmeyer, 2011). However, in our study the hypoxic stressor
appears to play a clear role. Another kind of RVH induction
in rats showed that the activation of AMPK by metformin
significantly reduced RVH, highlighting the importance of
AMPK in clinical treatments for RVH (Li et al., 2016).
Other evidence has demonstrated that pharmacological AMPK
activation attenuates the development of cardiac hypertrophy
by inhibiting protein synthesis through the inactivation of the
mammalian target of rapamycin (mTOR) signaling pathway
(Chan et al., 2004, 2008; Kang et al., 2011).
Thus, in the process of regulating ventricular hypertrophy
mTOR is involved. mTOR is the key sensor of nutrient status,
consisting of two distinct complexes, mTORC1 and mTORC2,
and its activation contributes to cell survival in cardiomyocytes
and regulates cell proliferation, apoptosis, cell migration and
metabolism. Moreover, the protective effects of AMPK on PO-
induced cardiac hypertrophy were recently shown to be partially
mediated by the inhibition of mTORC1 signaling but not
mTORC2 signaling (Li et al., 2014). This study, focused on
mTORC1, showed that only the CR group demonstrated no
activation of mTOR, which supports the role of the activation
of AMPK as a protector against RVH in high-altitude hypoxia
(hypobaric hypoxia).
Conversely, in the AL group exposed to CH, increased mTOR
activation and decreased AMPK activation showed an inverse
regulation between the two kinases. Further support for our
findings comes from reports demonstrating that the inhibition
of mTOR under chronic hypobaric hypoxic conditions resulted
in the prevention of RVH in an animal model (Paddenberg et al.,
2007) and that increased AMPK activity and decreased mTOR
activity attenuated RVH in pulmonary-artery-hypertension-
induced rats (Deng et al., 2017).
In this study, we have shown that the modification of
body weight through diet leads to reduced RVH under high-
altitude exposure. CR has been established as a potent dietary
intervention that produces beneficial cardiac effects (Kobara
et al., 2015; Melo et al., 2016) through AMPK activation,
which plays an important role in cardioprotection, as has been
demonstrated in the left ventricle (Shinmura et al., 2005, 2008;
Chen et al., 2013).
On the other hand, it was interesting to observe that the
PP2Cα expression level was increased in the AL group after CH
exposure but not in the CR group. This finding further supports
the lack of AMPK activation. Notably, the time of hypoxia
exposure in the CIH group was lower than that in the CH group.
This fact, could explain the reason to have a remarkably RVH in
AL’s chronic groups.
Many authors have described that AMPK inactivation by
dephosphorylation is attributed to PP2C (Davies et al., 1995;
Marley et al., 1996; Steinberg, 2007). This dephosphorylation
is enhanced under nutrient-rich conditions (the AL group of
this study) but deranged under nutrient-poor conditions (Davies
et al., 1995; Sanders et al., 2007; Hardie et al., 2012). The finding
of a lack of expression of this phosphatase would be another way
to explain the reduced hypertrophy in the CR group allowing
AMPK activation.
The aim of this study was to evaluate RVH in different
regimens of long-term hypoxia and not the degree of pulmonary
hypertension, which is well known that hypoxemia induce an
increase in pulmonary artery pressure and all the involved
mechanisms leading to RVH. Given that we cannot correlate both
proteins (AMPK and mTOR) with the actual degree of PAP at
any stage, this would be a limitation. However, in that sense, the
literature supports and describes that CR could decrease PAP
and RVH (Ding et al., 2015). Thence, in the current study, it
is clear that with CR, and the hypoxia regimen increased the
AMPK activity and inhibited mTOR, which might explain the
RVH that was found.
In addition, Wang and Unger (2005) suggested that AMPK
activity was reduced and the expression of PP2C was increased
significantly in the hearts of obese rats, which is rather in
agreement with the histological findings of more fat between
myocytes in the AL group, although the rats in these groups
were not obese. This study also has the limitation that
obese rats were not included, since the inclusion of obese
rats raises the concern of introducing a bias, and the main
aim was just to analyze CR in the development of RVH.
Another limitation of this study is the lack of assessment of
the cardiac functional status because the focus was more for
cardiac morphology.
CONCLUSION
This study contributes to a better understanding of the possible
relationship between body weight and AMPK activation in
the development of RVH under hypoxia. Caloric restriction,
either under CH or CIH, would be contributory to a
decreased degree of high-altitude-induced RVH through the
activation of AMPK. Nonetheless, further research is necessary
to corroborate this finding and whether it can be translated to
clinical grounds.
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